Corrigendum: “Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby “Six-Mix” amphiboles and subsequent activation of BEAS-2B cells” (Cytokine (2012) 60 (3) (718–730) (S1043466612006667) (10.1016/j.cyto.2012.08.025));Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby "six-mix" amphiboles and subsequent activation of BEAS-2B cells

Cytokine

Volumn 60, Issue 3, 2012, Pages 718-730

  Li, Muyao ^a   Gunter, Mickey E ^b,c   Fukagawa, Naomi K ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF IDAHO   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

Chrysotile asbestos; Epithelium; IL 1 ; Libby six mix amphiboles; Macrophage

Indexed keywords

EID: 84867980321     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2017.01.011     Document Type: Erratum

References (59)

1. Agency for Toxic Substances and Disease Registry. Asbestos: Health Effects, Retrieved April 10; 2009. http://www.atsdr.cdc.gov/asbestos/asbestos/health_effects/index.html.
2. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009, 27:451-483.
3. Dostert C., Petrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
4. Cassel S.L., Eisenbarth S.C., Iyer S.S., Sadler J.J., Colegio O.R., Tephly L.A., et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc Nat Acad Sci 2008, 105:9035-9040.
5. Palomäki J., Välimäki E., Sund J., Vippola M., Clausen P.A., Jensen K.A., et al. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 2011, 5:6861-6870.
6. Kummer J.A., Broekhuizen R., Everett H., Agostini L., Kuijk L., Martinon F., et al. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem 2007, 55:443-452.
7. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009, 27:229-265.
8. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008, 9:847-856.
9. Flavell R.A., Elinav E., Hu B., Sutterwala F., Eisenbarth S. KL1 the inflammasome in health and disease. Cytokine 2010, 52:2.
10. Peters M., Meyer zum Büschenfelde K.-H., Rose-John S. The function of the soluble IL-6 receptor in vivo. Immunol Lett 1996, 54:177-184.
11. Haegens A., van der Vliet A., Butnor K.J., Heintz N., Taatjes D., Hemenway D., et al. Asbestos-induced lung inflammation and epithelial cell proliferation are altered in myeloperoxidase-null mice. Cancer Res 2005, 65:9670-9677.
12. Shukla A., Lounsbury K.M., Barrett T.F., Gell J., Rincon M., Butnor K.J., et al. Asbestos-induced peribronchiolar cell proliferation and cytokine production are attenuated in lungs of protein kinase C-delta knockout mice. Am J Pathol 2007, 170:140-151.
13. Simeonova P.P., Toriumi W., Kommineni C., Erkan M., Munson A.E., Rom W.N., et al. Molecular regulation of IL-6 activation by asbestos in lung epithelial cells: role of reactive oxygen species. J Immunol 1997, 159:3921-3928.
14. Cummins A.B., Palmer C., Mossman B.T., Taatjes D.J. Persistent localization of activated extracellular signal-regulated kinases (ERK1/2) is epithelial cell-specific in an inhalation model of asbestosis. Am J Pathol 2003, 162:713-720.
15. Wang X., Samet J., Ghio A. Asbestos-induced activation of cell signaling pathways in human bronchial epithelial cells. Exp Lung Res 2006, 32:229-243.
16. Robledo R.F., Buder-Hoffmann S.A., Cummins A.B., Walsh E.S., Taatjes D.J., Mossman B.T. Increased phosphorylated extracellular signal-regulated kinase immunoreactivity associated with proliferative and morphologic lung alterations after chrysotile asbestos inhalation in mice. Am J Pathol 2000, 156:1307-1316.
17. Drumm K., Messner C., Kienast K. Reactive oxygen intermediate-release of fibre-exposed monocytes increases inflammatory cytokine-mRNA level, protein tyrosine kinase and NF-κB activity in co-cultured bronchial epithelial cells (BEAS-2B). Eur J Med Res 1999, 4:257-263.
18. Kienast K., Kaes C., Drumm K., Buhl R., Micke P., Oesch F., et al. Asbestos-exposed blood monocytes-deoxyribonucleic acid strand lesions in co-cultured bronchial epithelial cells. Scand J Work Environ Health 2000, 26:71-77.
19. Herseth J.I., Refsnes M., Lag M., Hetland G., Schwarze P.E. IL-1β as a determinant in silica-induced cytokine responses in monocyte-endothelial cell co-cultures. Hum Exp Toxicol 2008, 27:387-399.
20. Gunter M.E., Belluso E., Mottana A. Amphiboles: environmental and health concerns. Rev Mineral Geochem 2007, 67:453-516.
21. Campbell WJ, Huggins CW, Wylie AG. Chemical and physical characterization of amosite, chrysotile, crocidolite, and nonfibrous tremolite for oral ingestion studies by the National Institute of Environmental Health. Sciences 1980;8452:1-63.
22. Bandli B.R., Gunter M.E. A review of scientific literature examining the mining history, geology, mineralogy, and amphibole asbestos health effects of the Rainy Creek igneous complex, Libby, Montana, USA. Inhal Toxicol 2006, 18:949-962.
23. Meeker G.P., Bern A.M., Brownfield I.K., Lowers H.A., Sutley S.J., Hoefen T.M., et al. The composition and morphology of amphibole from the Rainy Creek Complex, near Libby, Montana. Am. Mineral. 2003, 88:1955-1969.
24. Bellamy J.M., Gunter M.E. Morphological characterization of Libby "six-mix" used in in vivo studies. Periodico Di Mineralogia 2008, 77:75-82.
25. Schwende H., Fitzke E., Ambs P., Dieter P. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J Leukoc Biol 1996, 59:555-561.
26. Tsuchiya S., Kobayashi Y., Goto Y., Okumura H., Nakae S., Konno T., et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 1982, 42:1530-1536.
27. Churg A., Wiggs B. Fiber size and number in workers exposed to processed chrysotile asbestos, chrysotile miners, and the general population. Am J Ind Med 1986, 9:143-152.
28. Groppo C., Tomatis M., Turci F., Gazzano E., Ghigo D., Compagnoni R., et al. Potential toxcity of nonregulated asbestiform minerals: balangeroite from the Western Alps. Part 1: identification and characterization. J Toxicol Environ Health A 2005, 68:1-19.
29. Hillegass J., Shukla A., MacPherson M., Lathrop S., Alexeeva V., Perkins T., et al. Mechanisms of oxidative stress and alterations in gene expression by Libby six-mix in human mesothelial cells. Parti Fibre Toxicol 2010, 7:26.
30. Valentine R., Chang M.J., Hart R.W., Finch G.L., Fisher G.L. Thermal modification of chrysotile asbestos: evidence for decreased cytotoxicity. Environ Health Perspect 1983, 51:357-368.
31. Shukla A., MacPherson M.B., Hillegass J., Ramos-Nino M.E., Alexeeva V., Vacek P.M., et al. Alterations in gene expression in human mesothelial cells correlate with mineral pathogenicity. Am J Respir Cell Mol Biol 2009, 41:114-123.
32. Li M., Chiu J.F., Mossman B.T., Fukagawa N.K. Down-regulation of manganese-superoxide dismutase through phosphorylation of FOXO3a by Akt in explanted vascular smooth muscle cells from old rats. J Biol Chem 2006, 281:40429-40439.
33. Li M., Chiu J.F., Kelsen A., Lu S.C., Fukagawa N.K. Identification and characterization of an Nrf2-mediated ARE upstream of the rat glutamate cysteine ligase catalytic subunit gene (GCLC). J Cell Biochem 2009, 107:944-954.
34. Blake D.J., Bolin C.M., Cox D.P., Cardozo-Pelaez F., Pfau J.C. Internalization of Libby amphibole asbestos and induction of oxidative stress in murine macrophages. Toxicol Sci 2007, 99:277-288.
35. Haegens A., Barrett T.F., Gell J., Shukla A., MacPherson M., Vacek P., et al. Airway epithelial NF-κB activation modulates asbestos-induced inflammation and mucin production in vivo. J Immunol 2007, 178:1800-1808.
36. Ramos-Nino M.E., Haegens A., Shukla A., Mossman B.T. Role of mitogen-activated protein kinases (MAPK) in cell injury and proliferation by environmental particulates. Mol Cell Biochem 2002, 234-235:111-118.
37. Johannessen C.M., Boehm J.S., Kim S.Y., Thomas S.R., Wardwell L., Johnson L.A., et al. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature 2010, 468:968-972.
38. Buss H., Dörrie A., Schmitz M.L., Hoffmann E., Resch K., Kracht M. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at Serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKε{lunate}, TRAF Family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 2004, 279:55633-55643.
39. Arend W.P., Palmer G., Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008, 223:20-38.
40. Bergsbaken T., Fink S.L., Cookson B.T. Pyroptosis: host cell death and inflammation. Nat Rev Micro 2009, 7:99-109.
41. Weber A, Wasiliew P, Kracht M. Interleukin-1 (IL-1) pathway. Sci Signal 2010;3:cm1.
42. Bauernfeind F., Ablasser A., Bartok E., Kim S., Schmid-Burgk J., Cavlar T., et al. Inflammasomes: current understanding and open questions. Cell Mol Life Sci 2010, 1-19.
43. Bauernfeind F.G., Horvath G., Stutz A., Alnemri E.S., MacDonald K., Speert D., et al. Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009, 183:787-791.
44. Gong Y.-N., Wang X., Wang J., Yang Z., Li S., Yang J., et al. Chemical probing reveals insights into the signaling mechanism of inflammasome activation. Cell Res 2010, 20:1289-1305.
45. Bauernfeind F., Bartok E., Rieger A., Franchi L., Núñez G., Hornung V. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J Immunol 2011, 187:613-617.
46. Bryant C., Fitzgerald K.A. Molecular mechanisms involved in inflammasome activation. Trends Cell Biol 2009, 19:455-464.
47. Tschopp J., Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?. Nat Rev Immunol 2010, 10:210-215.
48. Romani L., Fallarino F., De Luca A., Montagnoli C., D'Angelo C., Zelante T., et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008, 451:211-215.
49. van de Veerdonk F.L., Smeekens S.P., Joosten L.A.B., Kullberg B.J., Dinarello C.A., van der Meer J.W.M., et al. Reactive oxygen species-independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease. Proc Nat Acad Sci 2010, 107:3030-3033.
50. Meissner F., Molawi K., Zychlinsky A. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat Immunol 2008, 9:866-872.
51. Latz E. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 2010, 22:28-33.
52. Schroder K., Tschopp J. The Inflammasomes. Cell 2010, 140:821-832.
53. Donaldson K., Murphy F., Duffin R., Poland C. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010, 7:5.
54. Huang Q., Yang J., Lin Y., Walker C., Cheng J., Liu Z.G., et al. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat Immunol 2004, 5:98-103.
55. Dumitru C.D., Ceci J.D., Tsatsanis C., Kontoyiannis D., Stamatakis K., Lin J.-H., et al. TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 2000, 103:1071-1083.
56. Handoyo H., Stafford M.J., McManus E., Baltzis D., Peggie M., Cohen P. IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2. Biochem J 2009, 424:109-118.
57. Viatour P., Merville M.-P., Bours V., Chariot A. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005, 30:43-52.
58. Miki S., Iwano M., Miki Y., Yamamoto M., Tang B., Yokokawa K., et al. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 1989, 250:607-610.
59. Yeh H.H., Lai W.W., Chen H.H.W., Liu H.S., Su W.C. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene 2006, 25:4300-4309.